Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Odense Skønhedsklinik ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Bankruptcy risk for industry   5.4% 5.4% 5.4% 5.4% 5.4% 5.4% 5.4% 5.4%   Bankruptcy risk   14.3% 8.3% 9.3% 9.9% 5.4% 9.6% 14.6% 14.4%   Credit score (0-100)   16 31 26 24 41 20 2 3   Credit rating   B B B B BB B B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1.9 44.2 157 175 418 423 0.0 0.0   EBITDA   -98.3 44.1 -16.0 22.6 293 -105 0.0 0.0   EBIT   -136 9.6 -45.0 -15.1 187 -124 0.0 0.0   Pre-tax profit (PTP)   -136.6 9.5 -45.2 -15.4 182.3 -130.2 0.0 0.0   Net earnings   -134.9 9.5 -45.2 -15.4 176.7 -130.2 0.0 0.0   Pre-tax profit without non-rec. items   -137 9.5 -45.2 -15.4 182 -130 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Tangible assets total   65.7 112 34.4 23.6 12.7 46.6 0.0 0.0   Shareholders equity total   -119 -109 -154 -135 41.4 -88.8 -129 -129   Interest-bearing liabilities   162 198 213 178 132 167 129 129   Balance sheet total (assets)   182 227 214 159 244 159 0.0 0.0   Net Debt   155 196 191 144 0.8 134 129 129     See the entire balance sheet 1000.0 Volume  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1.9 44.2 157 175 418 423 0.0 0.0   Gross profit growth   -99.4% 2,216.5% 255.9% 11.1% 139.6% 1.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   182 227 214 159 244 159 0 0   Balance sheet change%   -19.2% 24.9% -5.7% -25.6% 53.2% -34.9% -100.0% 0.0%   Added value   -98.3 44.1 -16.0 22.6 224.4 -105.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -23 12 -107 -49 -118 16 -47 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 -2.0 1.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -7,156.0% 21.7% -28.7% -8.6% 44.6% -29.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -51.9% 3.0% -12.8% -4.5% 69.3% -50.2% 0.0% 0.0%   ROI %   -113.3% 5.3% -21.9% -7.7% 106.5% -72.8% 0.0% 0.0%   ROE %   -136.1% 4.7% -20.5% -8.3% 176.0% -130.0% 0.0% 0.0%   1000.0 Solidity  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Equity ratio %   -39.5% -32.4% -41.8% -45.9% 17.0% -35.8% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -158.1% 443.5% -1,192.5% 636.7% 0.3% -127.0% 0.0% 0.0%   Gearing %   -137.0% -181.3% -138.1% -131.4% 317.7% -187.7% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.1% 0.0% 0.1% 0.2% 2.8% 4.4% 0.0% 0.0%   1000.0 Liquidity  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.3 0.1 0.6 0.1 0.0 0.0   Current Ratio   0.2 0.2 0.5 0.4 1.0 0.4 0.0 0.0   Cash and cash equivalent   7.1 2.0 22.3 33.6 130.8 32.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -243.9 -281.9 -188.6 -181.3 6.2 -157.9 -64.4 -64.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/3 2019 2020/3 2020 2021/3 2021 2022/3 2022 2023/3 2023 2024/3 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -98 44 -16 23 224 -105 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -98 44 -16 23 293 -105 0 0   EBIT / employee   -136 10 -45 -15 187 -124 0 0   Net earnings / employee   -135 10 -45 -15 177 -130 0 0